~hagocytic cells contain a complicated enzyme system, termed NADPH oxidase, that is responsible for the production of toxic oxygen species (1). The enzyme transfers electrons from NADPH to 02, forming O2-, which then can dismutate into H202. Subsequently, other oxygen derivatives, such as hydroxyl radical and hypochlorous acid, may be formed. Collectively, these oxygen products are toxic to components in their environment, either phagocytosed or extracellular microorganisms or surrounding tissue (1, 2). Thus, the NADPH oxidase of phagocytic cells is an important participant in both host defense and inflammatory mechanisms. This is well-illustrated by the genetic disorder, chronic granulomatous disease (CGD), in which the NADPH oxidase enzyme is defective. Patients with CGD suffer from frequent and severe infections, as well as noninfectious complications, such as lymphadenopathy and hepatomegaly (3).
gesting each is unstable without the other. A few cases have been reported where cytochrome bsss is present, but nonfunctional, and these are usually caused by point mutations in the gene for either gp91-phox or p22-phox. These have been particularly informative for gaining insights into structure/ function relationships, as discussed below. Additional information on the molecular genetics of CGD can be found in recent excellent reviews (3, 12) .
Activation ofNADPH Oxidas~ NADPH oxidase is inactive until the cell is stimulated by phagocytosis or various inflammatory mediators (e.g., chemoattractants, cytokines). Binding of an agonist to its cell-surface receptor triggers various signal transduction pathways (13) . While a number of signaling intermediates (e.g., phospholipases, protein kinases) have been implicated as regulators of NADPH oxidase activation, a complete pathway has not been defined. Complexity is increased by the likelihood that multiple pathways are involved (14, 15) . However, it is dear that activation of NADPH oxidase culminates in assembly ofp47-phox and p67-phox with cytochrome bsss in the membrane (16) (17) (18) (19) (20) (21) . With the development of a cell-free system that models the assembly/activation process (3, (22) (23) (24) (25) (26) and the cloning of the NADPH oxidase components, it has been possible to begin addressing the structural features of the components involved.
Structure of NADPH Oxidase Components.
Cloning of the four NADPH oxidase components (27) (28) (29) (30) (31) (32) has revealed that the predicted sequence of each protein is unique, with only limited regions of similarity to other known proteins. The gp91-phox subunit of cytochrome bsss has weak homology to NADPH and FAD binding sites found in the ferredoxin reductase family of flavoproteins (33) (34) (35) (36) . This suggests that cytochrome bsss may be a flavocytochrome, capable of cartying out the entire electron transfer from NADPH to O2. Recent modds (36, 37) postulate that a conformational change in gp91-phox is needed to either enhance NADPH binding and/or fadlitate dectron transfer between NADPH and FAD. Such a conformational change could be induced by assembly of the cytosolic components with the cytochrome. Experimental support for cytochrome bsss as a flavocytochrome has appeared from several laboratories (20, 33-35, 38, 39) , although the modal is not universally accepted (40, 41) .
Several predicted structural features of p47-phox and p67-phox also are of interest. The COOH-terminal region ofp47-phox contains six to eight clustered putative phosphorylation sites. It has been shown that p47-phax is phosphoryhted during stimulation of intact neutrophils, yidding up to eight phosphospecies ranging from •pI 6.8 to 10 (42-44) . Phosphorylation of the dustered sites could dramatically alter the conformation of the protein (43) . However, direct evidence that phosphorylation of p47-phox is required for NADPH oxidase activation is lacking (45) (46) (47) (48) . Both p47-phox and p67-phox contain another important structural feature, Src homology 3 (SH3) domains. Each protein contains two of these regions (Fig. 1) . The newly described p40-phox also contains one SH3 region (10) . SH3 domains were originally described of the cytosolic NADPH ~idase components p47-phox and p67-phox (32) .
Each SH3 region is comprised of about 60 amino acid residues.
in the Src family of tyrosine kinases and are found in a variety of proteins involved in signal transduction (49) . They appear to mediate protein-protein interactions via binding to proline-rich sequences in target proteins (50) . Several of the oxidase components contain proline-rich sequences that could be binding sites for SH3 domains (51) (52) (53) . It is likely that SH3-mediated protein-protein interactions are involved in NADPH oxidase assembly, as discussed more fully below.
Requirement for SH3 Domains in NADPH Oxidase Activation. The SH3 regions of both p67-phox and p47-phox are necessary for NADPH oxidase activation. A role for the SH3 domain of p40-phox has not been explored. Studies by de Mendez et al. (54) showed that deletion mutants of p67-phox, lacking one or both SH3 regions, were unable to restore the ability to activate NADPH oxidase when transfected into p67-phox-deficient B cell lines derived from patients with this form of CGD. In contrast, p67-phox mutant proteins lacking the SH3 regions were active in a cell-free reconstitution system. This suggests that the SH3 domains ofp67-phox are required for a signaling function in the intact cell, but this function is bypassed or replaced by the activator in the cell-free system. 
Interaction of SH3 Domains with Pro-rich Sequences in NADPH Oxidase Components. Several groups recently have identified
interactions between proline-rich sequences in NADPH oxidase components and SH3 domains of p47-phox and p67-phox. Table 1 lists the Pro-rich sequences present in NADPH oxidase components, based on consensus sequences identified in other proteins (50) . At least three possible SH3 region/Prorich sequence interactions have experimental support, and each will be described separately. The first is binding between the second SH3 domain of p67-phox and the COOH-terminal Pro-rich sequence in p47-phox. Finan et al. (52) showed that a GST-fusion protein, containing the second SH3 domain of p67-phox, bound to p47-phox. Leto et al. (51) , in a complemen- results in a study using neutrophils from a patient with the P156Q mutation in p22-phox. Cells from the patient expressed normal levels of a cytochrome bsss that was nonfunctional for activation of NADPH oxidase, in agreement with a previous report (56) . Translocation of p47-phox and p67-phox to the membrane did not occur in either stimulated intact cells from the patient or the cell-free reconstitution system. The "nonfunctional" cytochrome was capable of electron transfer in an artificial cell-free system not requiring cytosolic components (37) . Thus, the P156Q mutation in p22-phox found in this patient prevents assembly of the NADPH oxidase complex, and no enzyme activation occurs. Collectively, these data support a model in which assembly of the cytosolic components with cytochrome bss8, mediated by SH3-region/Pro-rich sequence interactions between p47-phox and p67-phox and between p47-phox and p22-phox, results in a conformational change in gp91-phox necessary for transport of electrons from NADPH to 02 (Fig. 2) .
The P156Q mutation in p22-phox is the second example of a genetic disease caused by disruption of protein-protein interactions mediated by SH3 domains. Zhu et al. (58) recently reported a deletion in the SH3 region of Bruton's tyrosine kinase, which resulted in X-linked agammaglobulinemia.
The third SH3-dependent interaction of NADPH oxidase components involves intramolecular binding of the SH3 domains of p47-phox to Pro-rich sequences within the molecule. GST-fusion proteins containing the SH3 regions of p47-phox were shown by Leto et al. (51) and Sumimoto et al. (53) to bind to regions of p47-phox containing Pro-rich sequences. Data from the two groups are consistent in implicating the most COOH-terminal Pro-rich sequence in p47-phox (aa 358-390) as one binding site. Leto et al. also provided evidence suggesting the most NH2-terminal Pro-rich sequence (aa 70-84) is a second target. Additional studies with synthetic peptides and mutant or truncated proteins are needed to pinpoint the interaction sites more clearly. Leto et al. (51) speculate that such an intramolecular interaction in p47-phox folds the molecule in an "inactive" state, and the interaction must be disrupted in order for assembly of NADPH oxidase components to occur (Fig. 2) . Experimental evidence to support this model was provided by Sumimoto et al. (53) . A monoclonal antibody specific for the SH3 domains of p47-phox immunoprecipitated native p47-phox (present in cytosolic fractions from HL-60 cells differentiated along the neutrophilic pathway) only in the presence of arachidonic acid or SDS. These amphiphilic molecules are used in cell-free reconstitution systems to induce assembly and activation of NADPH oxidase. Possibly, the amphiphiles induce a conformational change in p47-phox, "unmasking" the SH3 regions to allow interaction with other NADPH oxidase components. One can speculate that a physiological mechanism to achieve this conformational change is phosphorylation of multiple sites in the COOH-terminal region of p47-phox. Conclusion. Considerable progress has been made in understanding the SH3-dependent interactions between components of NADPH oxidase. Such interactions appear to be crucial for assembly of an active enzyme. An intriguing model for SH3-mediated assembly, consistent with the data summarized here, has been put forth by Leto et al. (51) (see Fig.  2 and discussions above). Future research with this complex enzyme system will test and modify this model. What a fascinating story is unfolding! I thank Tom Leto for sharing his results and model prior to publication.
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